6 CEOs Weigh In On The Supply Chain Nationalism And The Reshoring Of Biopharma Manufacturing
6 CEOs Weigh In On The Supply Chain, Nationalism, And The Reshoring Of Biopharma Manufacturing Source: Life Science Leader Follow Me On Twitter @RfwrightLSL The pandemic has certainly been a pain in the neck. But it also has brought to light many opportunities for the biopharmaceutical industry. For example, back in March, China threatened to cut off the supply of medicines it makes to the United States. Most of us knew that a significant amount of biopharmaceutical manufacturing had been offshored to places like China and India. However, most of us (despite Louis Garguilo, chief editor of O...